These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 26798647)
1. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance. Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647 [TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE; Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451 [TBL] [Abstract][Full Text] [Related]
3. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Palmer AJ; Tucker DM Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada. Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090 [TBL] [Abstract][Full Text] [Related]
5. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075 [TBL] [Abstract][Full Text] [Related]
6. Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data. Leal J; Reed SD; Patel R; Rivero-Arias O; Li Y; Schulman KA; Califf RM; Holman RR; Gray AM Diabetes Care; 2020 Oct; 43(10):2485-2492. PubMed ID: 32796009 [TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J Trials; 2015 Nov; 16():496. PubMed ID: 26530718 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Eddy DM; Schlessinger L; Kahn R Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469 [TBL] [Abstract][Full Text] [Related]
10. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. Liu X; Li C; Gong H; Cui Z; Fan L; Yu W; Zhang C; Ma J BMC Public Health; 2013 Aug; 13():729. PubMed ID: 23919839 [TBL] [Abstract][Full Text] [Related]
11. A simulation model estimates lifetime health and economic outcomes of screening prediabetes using the 1-h plasma glucose. Andellini M; Manco M; Esposito MT; Tozzi AE; Bergman M; Ritrovato M Acta Diabetol; 2023 Jan; 60(1):9-17. PubMed ID: 36127565 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes. van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis. Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A Value Health; 2010; 13(2):196-208. PubMed ID: 19878493 [TBL] [Abstract][Full Text] [Related]
14. A review of the economic evidence for acarbose in the prevention of diabetes and cardiovascular events in individuals with impaired glucose tolerance. Josse RG; McGuire AJ; Saal GB Int J Clin Pract; 2006 Jul; 60(7):847-55. PubMed ID: 16858756 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program. Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study. Hu W; Xu W; Si L; Wang C; Jiang Q; Wang L; Cutler H PLoS One; 2020; 15(12):e0242962. PubMed ID: 33382746 [TBL] [Abstract][Full Text] [Related]
17. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Prevention Program Research Group Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report. Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of a digital diabetes-prevention programme versus an in-person diabetes-prevention programme in people with prediabetes in the United States. Park S; Ballreich J; Ward T; Shi L Diabetes Obes Metab; 2024 Oct; 26(10):4522-4534. PubMed ID: 39056211 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]